Compare Mongodb Inc (MDB) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mongodb Inc vs Zoetis Inc — how do they compare? Mongodb Inc trades at $307.65 (market cap $26.01B), while Zoetis Inc trades at $75.53 (market cap $31.95B). The key difference: Zoetis Inc is the larger of the two by market cap, and Zoetis Inc pays a 2.78% dividend while Mongodb Inc pays none. Which is the better fit depends on your goals.
| MDB | ZTS | |
|---|---|---|
Market Cap | $26.01B | $31.95B |
Sector | Technology | Health |
52-Week High | $440.25 | $156.76 |
52-Week Low | $201.08 | $71.91 |
Enterprise Value | $23.61B | $39.24B |
Dividend Yield | — | 2.78% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MDB trades at $307.65, down 1.5% today, with a bearish technical signal despite recent earnings beats. Revenue growth is strong at $2.01B for 2025, but the company remains unprofitable with a net margin of -1.12%. Analyst sentiment is overwhelmingly positive with an 81.81% buy rating and a $400.39 consensus price target, though negative cash flow and high valuation multiples present challenges.
The outlook hinges on MDB's ability to sustain revenue momentum and achieve profitability. Investment opportunity lies in its leadership in database solutions and AI-driven demand growth. Key risks include persistent cash burn, competitive pressures, and high valuation metrics that may not justify current losses if growth slows.
Zoetis (ZTS) trades at $75.33, down 1.61% amid mixed technical signals and ongoing securities litigation. The stock shows strong fundamentals with a 28.03% net margin and 67.75% ROE, supported by consistent revenue growth from $8.1B in 2022 to $9.47B in 2025. Recent earnings beat expectations in Q3 and Q4 2025 but missed in Q1 2026, with Q2 results pending. Analyst consensus remains positive with a $101.43 price target, though technical indicators show neutral momentum near key support at $75.
The outlook for ZTS is cautiously optimistic given robust profitability and analyst support, but significant legal overhangs and recent earnings volatility present near-term risks. Long-term growth in animal health markets offers upside, yet investors should monitor litigation developments and Q2 earnings for directional cues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Mongodb Inc
Founded in 2007, MongoDB is a document-oriented database with nearly 33,000 paying customers and well past 1.5 million free users. MongoDB provides both licenses as well as subscriptions as a service for its NoSQL database. MongoDB's database is compatible with all major programming languages and is capable of being deployed for a variety of use cases.
Read more on MDB →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
